Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan K Burnett

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|July 16, 2018
Treatment of Older Patients With Newly Diagnosed AML Unfit for Traditional TherapyAlan K Burnett
Current Opinion in Hematology|January 18, 2012
New induction and postinduction strategies in acute myeloid leukemiaAlan K Burnett
Hematology. American Society of Hematology. Education Program|December 13, 2012
Treatment of acute myeloid leukemia: are we making progress?Alan K Burnett
The Hematology Journal : the Official Journal of the European Haematology Association|June 11, 2004
A European network for AMLAlan K Burnett
Clinical Medicine (London, England)|December 4, 2013
Treatment of acute myeloid leukaemiaAlan K Burnett
Mediterranean Journal of Hematology and Infectious Diseases|June 25, 2013
The Challenge of AML in Older PatientsAlan K Burnett
Reviews in Clinical and Experimental Hematology|June 13, 2002
Acute myeloid leukemia: treatment of adults under 60 yearsAlan K Burnett
British Journal of Haematology|July 26, 2002
Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--an adult treater's viewAlan K Burnett
Hematology (Amsterdam, Netherlands)|September 29, 2005
The treatment of AML: current status and novel approachesAlan K Burnett
Drugs of Today (Barcelona, Spain : 1998)|January 5, 2008
Tipifarnib in acute myeloid leukemiaAlan K Burnett, Jonathan Kell
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Clinical Lymphoma, Myeloma & Leukemia|July 16, 2018
Treatment of Older Patients With Newly Diagnosed AML Unfit for Traditional TherapyAlan K Burnett
Current Opinion in Hematology|January 18, 2012
New induction and postinduction strategies in acute myeloid leukemiaAlan K Burnett
Hematology. American Society of Hematology. Education Program|December 13, 2012
Treatment of acute myeloid leukemia: are we making progress?Alan K Burnett
The Hematology Journal : the Official Journal of the European Haematology Association|June 11, 2004
A European network for AMLAlan K Burnett
Clinical Medicine (London, England)|December 4, 2013
Treatment of acute myeloid leukaemiaAlan K Burnett
Mediterranean Journal of Hematology and Infectious Diseases|June 25, 2013
The Challenge of AML in Older PatientsAlan K Burnett
Reviews in Clinical and Experimental Hematology|June 13, 2002
Acute myeloid leukemia: treatment of adults under 60 yearsAlan K Burnett
British Journal of Haematology|July 26, 2002
Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--an adult treater's viewAlan K Burnett
Hematology (Amsterdam, Netherlands)|September 29, 2005
The treatment of AML: current status and novel approachesAlan K Burnett
Drugs of Today (Barcelona, Spain : 1998)|January 5, 2008
Tipifarnib in acute myeloid leukemiaAlan K Burnett, Jonathan Kell
Pageof 14